These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37573150)

  • 21. Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial.
    Stadtmauer EA; Pasquini MC; Blackwell B; Hari P; Bashey A; Devine S; Efebera Y; Ganguly S; Gasparetto C; Geller N; Horowitz MM; Koreth J; Knust K; Landau H; Brunstein C; McCarthy P; Nelson C; Qazilbash MH; Shah N; Vesole DH; Vij R; Vogl DT; Giralt S; Somlo G; Krishnan A
    J Clin Oncol; 2019 Mar; 37(7):589-597. PubMed ID: 30653422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Second stem cell transplantation for treatment of relapsed/refractory multiple myeloma after first autologous stem cell transplant: A 15-year retrospective institutional analysis.
    Yadav N; Mirgh SP; Aggarwal M; Agrawal N; Mehta P; Khushoo V; Kapoor J; Bhatia N; Agrawal P; Ahmed R; Bhurani D
    Indian J Cancer; 2023; 60(3):316-324. PubMed ID: 37787191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Levofloxacin Prophylaxis on Bacteremia in Children With Acute Leukemia or Undergoing Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial.
    Alexander S; Fisher BT; Gaur AH; Dvorak CC; Villa Luna D; Dang H; Chen L; Green M; Nieder ML; Fisher B; Bailey LC; Wiernikowski J; Sung L;
    JAMA; 2018 Sep; 320(10):995-1004. PubMed ID: 30208456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serological Response to Vaccination after Autologous Transplantation for Multiple Myeloma Is Associated with Improved Progression-Free and Overall Survival.
    Merz AMA; Merz M; Zhang Y; Stecklein K; Pleskow J; Chen GL; Buck DA; Mohammadpour H; Herr MM; Elshoury A; Hillengass J; McCarthy PL; Hahn T
    Transplant Cell Ther; 2021 Mar; 27(3):245.e1-245.e8. PubMed ID: 34706824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma, and multiple myeloma.
    Auner HW; Sill H; Mulabecirovic A; Linkesch W; Krause R
    Ann Hematol; 2002 Jul; 81(7):374-7. PubMed ID: 12185506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of a change in antibacterial prophylaxis on bacteremia and hospitalization rates following outpatient autologous peripheral blood stem cell transplantation for multiple myeloma.
    Kim JH; Goulston C; Zangari M; Tricot G; Boyer MW; Hanson KE
    Transpl Infect Dis; 2014 Jun; 16(3):421-9. PubMed ID: 24797543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Patient Outcomes With Two Different Formulations of Melphalan as Conditioning Chemotherapy for Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.
    Khan AM; Yucebay F; Zhao Q; Umyarova E; Cottini F; Bumma N; Rosko A; Benson D; Sharma N; Efebera Y; Devarakonda S
    Clin Lymphoma Myeloma Leuk; 2023 Feb; 23(2):e85-e96. PubMed ID: 36411211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Daratumumab, pomalidomide, and dexamethasone (DPd) followed by high dose chemotherapy-Autologous Stem Cell Transplantation leads to superior outcomes when compared to DPd-alone for patients with Relapsed Refractory Multiple Myeloma.
    Hashmi H; Atrash S; Jain J; Khasawneh G; Mohan M; Mahmoudjafari Z; Cui W; McGuirk J; Shune L; Ahmed N; Abdallah AO
    Transplant Cell Ther; 2023 Apr; 29(4):262.e1-262.e6. PubMed ID: 36682468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strategies to improve the outcome of stem cell transplantation in multiple myeloma.
    Catley L; Anderson K
    Hematol J; 2004; 5(1):9-23. PubMed ID: 14745425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Socioeconomic Status with Outcomes of Autologous Hematopoietic Cell Transplantation for Multiple Myeloma.
    Hong S; Rybicki L; Abounader D; Bolwell BJ; Dean R; Gerds AT; Hamilton BK; Hill BT; Jagadeesh D; Kalaycio M; Liu HD; Pohlman B; Sobecks R; Majhail NS
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1141-1144. PubMed ID: 26995694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time.
    Kumar SK; Dispenzieri A; Fraser R; Mingwei F; Akpek G; Cornell R; Kharfan-Dabaja M; Freytes C; Hashmi S; Hildebrandt G; Holmberg L; Kyle R; Lazarus H; Lee C; Mikhael J; Nishihori T; Tay J; Usmani S; Vesole D; Vij R; Wirk B; Krishnan A; Gasparetto C; Mark T; Nieto Y; Hari P; D'Souza A
    Leukemia; 2018 Apr; 32(4):986-995. PubMed ID: 29263438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The Preventive Effect of Levofloxacin Combined with G-CSF or Only G-CSF Supportive Therapy on Infection in Autologous Hematopoietic Stem Cell Transplantation].
    Wang XW; Yang LP; Yao Q; Zhao J; He SL; Ma LM; Wei JN; Tian WW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):906-910. PubMed ID: 38926987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catheter-Related Thrombosis in Patients with Lymphoma or Myeloma Undergoing Autologous Stem Cell Transplantation.
    Hegerova L; Bachan A; Cao Q; Vu HX; Rogosheske J; Reding MT; Brunstein CG; Arora M; Ustun C; Vercellotti GM; Bachanova V
    Biol Blood Marrow Transplant; 2018 Dec; 24(12):e20-e25. PubMed ID: 30053647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR report.
    Schriber JR; Hari PN; Ahn KW; Fei M; Costa LJ; Kharfan-Dabaja MA; Angel-Diaz M; Gale RP; Ganguly S; Girnius SK; Hashmi S; Pawarode A; Vesole DH; Wiernik PH; Wirk BM; Marks DI; Nishihori T; Olsson RF; Usmani SZ; Mark TM; Nieto YL; D'Souza A
    Cancer; 2017 Aug; 123(16):3141-3149. PubMed ID: 28472539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Body mass index does not impact hematopoietic progenitor cell mobilization for autologous hematopoietic cell transplantation.
    Khouri J; Rybicki L; Majhail NS; Kalaycio M; Pohlman B; Hill B; Jagadeesh D; Dean R; Hamilton B; Sobecks R; Koo A; Liu H
    J Clin Apher; 2019 Dec; 34(6):638-645. PubMed ID: 31381194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic levofloxacin in pediatric neutropenic patients during autologous hematopoietic stem cell transplantation.
    Hafez HA; Yousif D; Abbassi M; Elborai Y; Elhaddad A
    Clin Transplant; 2015 Dec; 29(12):1112-8. PubMed ID: 26363413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of upfront autologous hematopoietic cell transplantation in patients with multiple myeloma who are 75 years old or older.
    Munshi PN; Vesole DH; St Martin A; Davila O; Kumar S; Qazilbash M; Shah N; Hari PN; D'Souza A
    Cancer; 2021 Nov; 127(22):4233-4239. PubMed ID: 34374445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infectious Complications in Patients With Multiple Myeloma After High-Dose Chemotherapy Followed by Autologous Stem Cell Transplant: Nationwide Study of the Infectious Complications Study Group of the Polish Adult Leukemia Group.
    Waszczuk-Gajda A; Drozd-Sokołowska J; Basak GW; Piekarska A; Mensah-Glanowska P; Sadowska-Klasa A; Wierzbowska A; Rzepecki P; Tomaszewska A; Mańko J; Hus M; Adamska M; Romejko-Jarosińska J; Dybko J; Biernat M; Kyrcz-Krzemień S; Sędzimirska M; Winciorek N; Jędrzejczak WW; Styczyński J; Giebel S; Gil L
    Transplant Proc; 2020 Sep; 52(7):2178-2185. PubMed ID: 32217016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bortezomib-based induction therapy followed by autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients: A single-center experience and review of Indian literature.
    Kathrotiya M; Radhakrishnan V; Bhave SJ; Nag A; Arora N; Roychoudhry M; Parihar M; Mishra D; Nair R; Chandy M; Kumar J
    Indian J Cancer; 2023 Oct; 60(4):486-492. PubMed ID: 38258869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survivorship after Autologous Hematopoietic Cell Transplantation for Lymphoma and Multiple Myeloma: Late Effects and Quality of Life.
    Georges GE; Bar M; Onstad L; Yi JC; Shadman M; Flowers ME; Carpenter PA; Stewart S; Lee SJ; Holmberg LA
    Biol Blood Marrow Transplant; 2020 Feb; 26(2):407-412. PubMed ID: 31605822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.